About LabCentral
LabCentral is a company based in Cambridge (United States) founded in 2012. LabCentral has raised $13 million across 2 funding rounds from investors including Astellas Pharma and Massachusetts Life Sciences Center. The company has 91 employees as of December 31, 2023. LabCentral offers products and services including Lab Spaces, Golden Tickets, and Startup Programs. LabCentral operates in a competitive market with competitors including SmartLabs, NSG BioLabs, Livance, LabShares and BioLabs, among others.
- Headquarter Cambridge, United States
- Employees 91 as on 31 Dec, 2023
-
Sectors
Real Estate & ConstructionHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Labcentral Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13 M (USD)
in 2 rounds
-
Latest Funding Round
$13 M (USD), Series B
Oct 01, 2019
-
Investors
Astellas Pharma
& 1 more
-
Employee Count
91
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LabCentral
LabCentral offers a comprehensive portfolio of products and services, including Lab Spaces, Golden Tickets, and Startup Programs.
Provides equipped labs for biotech research and development
Offers funding opportunities for startup founders in biotech
Delivers resources and training for early-stage innovators
People of LabCentral
Unlock access to complete
Funding Insights of LabCentral
LabCentral has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LabCentral
LabCentral has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Astellas Pharma and Massachusetts Life Sciences Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences innovation is supported through funding and programs.
|
Locked | Locked | Locked | |
|
Generic pharmaceuticals are developed, manufactured, and marketed worldwide.
|
Locked | Locked | Locked |
Investor details for LabCentral
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabCentral
Investment portfolio details for LabCentral
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LabCentral
Detailed financials for LabCentral
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Labcentral Comparisons
Peer comparison for LabCentral
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LabCentral
LabCentral operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SmartLabs, NSG BioLabs, Livance, LabShares and BioLabs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Coworking lab spaces for research teams are provided by SmartLabs.
|
|
| Locked | Locked | Locked |
Level 2 biosafety co-working labs and office spaces are provided.
|
|
| Locked | Locked | Locked |
Managed medical co-working spaces are provided on a pay-as-you-go basis.
|
|
| Locked | Locked | Locked |
Provider of shared and private laboratory spaces with equipment and services.
|
|
| Locked | Locked | Locked |
Provides co-working lab and office spaces for biotech startups.
|
Detailed competitors of LabCentral
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Labcentral
Complete news archive for LabCentral
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LabCentral
LabCentral was founded in 2012 and raised its 1st funding round 7 years after it was founded.
LabCentral is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Maggie Otoole is the current CEO of LabCentral.
LabCentral is a funded company, having raised a total of $13M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at LabCentral is 91.
LabCentral was established in 2012 as a non-profit entity in Cambridge, United States, focused on the biotech sector. Permitted laboratory and office spaces are supplied to early-stage startups comprising scientists and entrepreneurs. Administrative support, skilled laboratory staff, a series of expert speakers in relevant domains, and essential services for launching lab operations are made available to residents.
LabCentral's top competitors include SmartLabs, NSG BioLabs and Livance.
LabCentral offers Lab Spaces, Golden Tickets, and Startup Programs.
LabCentral has 2 investors. Key investors include Astellas Pharma, and Massachusetts Life Sciences Center.